(2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide

C21H23F2N7O3 — CID 167438738

IUPAC(2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide
SMILESCNC(=O)[C@@H]1CN(c2ccc(OCc3c(C)nnn3-c3ccc(C(F)F)cc3)nn2)CCO1
InChIInChI=1S/C21H23F2N7O3/c1-13-16(30(28-25-13)15-5-3-14(4-6-15)20(22)23)12-33-19-8-7-18(26-27-19)29-9-10-32-17(11-29)21(31)24-2/h3-8,17,20H,9-12H2,1-2H3,(H,24,31)/t17-/m0/s1
InChIKeyDULABYUPAOHDCN-KRWDZBQOSA-N
MW459.46 g/mol
LogP1.83
Rot. Bonds7

About (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide

(2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide (PubChem CID 167438738) has the molecular formula C21H23F2N7O3 and a molecular weight of 459.46 g/mol. Its IUPAC name is (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide.

Molecular Properties

Compound Name(2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide
PubChem CID167438738
Molecular FormulaC21H23F2N7O3
Molecular Weight459.46 g/mol
Exact Mass459.18
IUPAC Name(2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide
SMILESCNC(=O)[C@@H]1CN(c2ccc(OCc3c(C)nnn3-c3ccc(C(F)F)cc3)nn2)CCO1
InChIInChI=1S/C21H23F2N7O3/c1-13-16(30(28-25-13)15-5-3-14(4-6-15)20(22)23)12-33-19-8-7-18(26-27-19)29-9-10-32-17(11-29)21(31)24-2/h3-8,17,20H,9-12H2,1-2H3,(H,24,31)/t17-/m0/s1
InChIKeyDULABYUPAOHDCN-KRWDZBQOSA-N
XLogP1.83
TPSA107.29 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms33
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500459.46
LogP ≤ 51.83
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide?
The IUPAC name of (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide (CID 167438738) is (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide.
What is the SMILES notation for (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide?
The canonical SMILES for (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide is CNC(=O)[C@@H]1CN(c2ccc(OCc3c(C)nnn3-c3ccc(C(F)F)cc3)nn2)CCO1.
What is the InChIKey of (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide?
The InChIKey is DULABYUPAOHDCN-KRWDZBQOSA-N. The full InChI is InChI=1S/C21H23F2N7O3/c1-13-16(30(28-25-13)15-5-3-14(4-6-15)20(22)23)12-33-19-8-7-18(26-27-19)29-9-10-32-17(11-29)21(31)24-2/h3-8,17,20H,9-12H2,1-2H3,(H,24,31)/t17-/m0/s1.
What are the key properties of (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide?
(2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide has a molecular weight of 459.46 g/mol, XLogP of 1.83, 7 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-4-[6-[[3-[4-(difluoromethyl)phenyl]-5-methyltriazol-4-yl]methoxy]pyridazin-3-yl]-N-methylmorpholine-2-carboxamide is sourced from PubChem (CID 167438738), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).